MONDAY, June 13, 2022 (HealthDay News) — An experimental drug for the neurological disorder ALS was approved in Canada on Monday, but an ongoing evaluation of the treatment by the U.S. Food and Drug Administration has raised questions about its effectiveness. A condition of Health Canada’s approval of Albrioza (AMX0035)Continue Reading

MONDAY, June 13, 2022 (HealthDay News) — Called “forever chemicals” because they linger in the environment, new research suggests that middle-aged women with high levels of perfluoroalkyls and polyfluoroalkyls (PFAS) in their blood may be more vulnerable to high blood pressure. In the study, women aged 45 to 56 whoContinue Reading

MONDAY, June 13, 2022 (HealthDay News) — New research gives new meaning to the term “hotheaded” — your normal brain temperature is higher and varies much more than previously thought. The findings could lead to future research into whether disruption of daily brain temperature rhythms might trigger dementia and otherContinue Reading

For some 911 calls, are mental health specialists the better choice? One American city’s innovative approach to handling low-level 911 calls — sending mental health professionals rather than police — may have taken a bite out of crime. Read more FDA seems to support Pfizer, Moderna COVID shots for youngestContinue Reading

MONDAY, June 13, 2022 (HealthDay News) — It’s OK to drink coffee soon after taking a liquid thyroid medication, a new study finds. Current product labels and treatment guidelines recommend patients take thyroid hormone replacement therapy on an empty stomach, but this new research shows that absorption of liquid levothyroxineContinue Reading